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ABSTRACT 
Objective: To investigate the difference in expression of CD146 
immunohistochemical staining on intermediate trophoblast in early and late onset 
pre-eclampsia placentas as well as comparing this expression to gestational age 
matched control placentas. 
Study Design: Retrospective case series of 100 placentas: 25 early onset and 
25 late onset pre-eclampsia placentas as well as 25 early and 25 late gestational age 
matched control placentas. Placentas were obtained from patients delivering in 
Tygerberg Hospital. 
Methods: Placentas were routinely fixed and processed. 2 sections of one 
preselected block from each case was cut and stained with CD146 and MNF116 
immunohistochemical stain. The expression of the staining would be performed by 
means of analytical and image analysing software. 
Results: The study failed to demonstrate differences in CD146 expression by 
the intermediate trophoblast in the pre-eclampsia and control placentas. The 
analytical approach was deemed to be subjective and the image analysing software 
had too much background staining and inaccurate identification of the intermediate 
trophoblast in order to produce reproducible consistent results. 
Conclusion: Dual staining, using immunofluorescent staining of CD146 and 
MNF116 on smaller biopsies of the decidua are thought to be able to produce 
much better material for image analyses software. 
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1.  INTRODUCTION and LITERATURE REVIEW 
Pre-eclampsia is a pregnancy associated hypertensive disorder, occurring in 5 
- 8% of pregnancies, after 20 weeks of gestation with a new presentation of 
hypertension and proteinuria.1-3 The disease can present earlier (prior to 20 weeks 
gestation), particularly if it is associated with trophoblastic disease (i.e. molar 
pregnancy or hydrops; disorders that typically have large bulky placentas).1  
Although the disease manifests with hypertension and proteinuria it actually 
represents a systemic maternal inflammatory disorder with endothelial dysfunction. 
4-6  
Pre-eclampsia also seems to be more common in patients who have 
microvascular disease or metabolic disorders that predispose to endothelial 
dysfunction (hypertension, diabetes mellitus, obesity and renal disease).7,8  
 
1.1.  Definition of Hypertensive disorders in 
pregnancy. 
In 2000 the International Society for the Study of Hypertension in Pregnancy 
(ISSHP) produced a paper to try to establish a uniform classification system and 
diagnostic criteria for pre-eclampsia.2 Hypertensive disorders are classified as: 
Chronic hypertension, Pre-eclampsia-eclampsia, Pre-eclampsia superimposed on 
chronic hypertension.1,2 These were defined as: 
Chronic hypertension: hypertension diagnosed prior to 20 weeks gestation. 
This also includes de novo hypertension that develops late in pregnancy and 
does not resolve postpartum. 
Pre-eclampsia-eclampsia: hypertension and proteinuria that develops after 20 
weeks gestation and normalizes post partum. Hypertension is defined as 
blood pressure >140/90mmHg and proteinuria as >300mg/day. If 
proteinuria is absent, pre-eclampsia can still be suspected if one of the 
following is present: renal insufficiency (creatinine ≥ 90µmmol/L or 
oliguria), liver disease (raised transaminases and/or severe right upper 
quadrant pain), hematological disturbances (thrombocytopenia, DIC, 
hemolysis), fetal growth restriction and neurological features [convulsions 
(eclampsia), hyperreflexia with clonus, severe headaches with 
hyperreflexia, persistent visual disturbances].1 
Pre-eclampsia superimposed on chronic hypertension: development of 
features of pre-eclampsia (new onset proteinuria with the loss of blood 
pressure control) in a woman with pre-existing hypertension. The 
hypertension persists postpartum. 
 
1.2.  Problem(s) with Pre-eclampsia Diagnostic 
Criteria 
Although there has been a tremendous amount of work put into trying to 
standardize the diagnostic criteria for pre-eclampsia, it is however 
acknowledged by the ISSHP that the criteria are somewhat ‘restrictive’ in 
that a woman with a blood pressure of 139/89mmHg does not qualify for 
the diagnosis, nor does proteinuria of 290mg/day.2 It would seem as if these 
cut off criteria are too restrictive. 
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The diagnostic criteria are also deficient in identifying the clinical phase of pre-
eclampsia (i.e. the symptomatic maternal phase of the disease), and can 
miss the woman in the latent phase of the disease.7,8 Evaluation of raised 
blood pressure also is not sufficient to define the entire haemodynamic 
abnormality that occurs in the setting of pre-eclampsia.8 
As pre-eclampsia is an ominous disorder worldwide with a high mortality and 
morbidity rate in South Africa, it is recommended that it is better to over 
diagnose this condition when trying to differentiate it from gestational 
hypertension as this will lead to better monitoring and more aggressive and 
early therapy. 2,9,10, 11   
There is also evidence that woman with early onset pre-eclampsia (before 34 
weeks of gestation) are particularly at a higher risk of developing 
cardiovascular disease later in life.6 The rationale behind this is that both 
pre-eclampsia and atherosclerosis share risk factors for systemic 
inflammation and endothelial dysfunction. These factors include: obesity, 
dyslipidemia, diabetes mellitus and insulin resistance, hypertension, 
endothelial dysfunction and a family history.6  Another theory also suggests 
that in pre-eclampsia maternal vessels also suffer damage which promotes 
further maternal atherosclerosis.6 
 
 
2.  PATHOGENESIS of PRE-ECLAMPSIA 
The pathogenesis of pre-eclampsia has always been ascribed to the 
incomplete or superficial invasion of the trophoblast into the endometrium/ 
myometrium with incomplete “physiological” transformation of the spiral 
arterioles with subsequent inadequate placental perfusion.7,12 The cause for this 
poor trophoblastic invasion is as yet unknown. The resultant placental ischemia-
reperfusion injury causes a release of biological active factors (molecules and 
particles) into the maternal vascular circulatory system, which results in excessive 
oxidative and inflammatory stress in the maternal circulation with endothelial 
dysfunction and manifests with the clinical phase of the disease. 4,7,12  
In the first 10 weeks of gestation the embryo is fed by the endometrial glands 
and lives in a low oxygen environment. This relative hypoxia induces the 
cytotrophoblast to invade the decidua and myometrium and remodel the spiral 
arterioles. Initially the cytotrophoblast occludes the arterioles and reduces the 
blood supply to the embryo as the high blood pressure would induce a termination 
of the conceptus.13 Within 8-18 weeks however the spiral arterioles are remodelled 
with loss of their muscular walls and endothelial lining and their diameter 
increases five to ten fold.5,7,14 This modification extends up to the inner third of the 
myometrium. This change does not occur normally in pre-eclampsia, where some 
vessels are only modestly (incompletely) remodelled while others are not 
remodelled at all (resulting in the placental lesion called decidual vasculopathy).7 
These changes can be found histologically in roughly half the placentas examined 
as frequently only the superficial decidualised endometrium is attached to the 
placenta and is available for examination. It is predominantly the endovascular 
invasion that is affected in pre-eclampsia but not the interstitial invasion of the 
trophoblast.5,6  
The pathological lesion of decidual vasculopathy, the most characteristic 
variant of which is acute atherosis, is however not limited to pre-eclampsia and can 
Dr Pawel T. Schubert 
Anatomical Pathology                                                                                                                                                                   2014 
Universities of Stellenbosch & Cape Town                                                                                               Student No: SCHPAW001 
Master of Philosophy (Paediatric Pathology) 
University of Cape Town 
3 
also be encountered in placentas’ from idiopathic fetal growth restricted infants, in 
cases of hypertension without proteinuria and autoimmune diseases, particularly 
lupus erythematosus, scleroderma and anti-phosolipid antibody syndrome and 
rarely even in placentas from normal pregnancy.5,6,15-18  At this stage it is not 
understood why some placentas with incompletely remodelled spiral arterioles 
develop pre-eclampsia and others do not. 
These vascular changes lead to ischemia-reperfusion injury to the placenta 
parenchyma with resultant placental oxidative and endoplasmic reticulum stress.19 
This leads to the release of inflammatory factors into the maternal circulation, 
which include amongst others trophoblast derived pro- and anti-angiogenic 
proteins, trophoblast-derived micro- and nanovesicles and other proinflammatory 
products as well as activating AT1-receptor antibodies.4 
 
3.  PRE-ECLAMPSIA: two variants of the disease 
Clinically pre-eclampsia can be distinguished into two patterns of 
presentation, an early onset form (<34weeks gestation) and a late onset form, 
>34weeks gestation.3,8,20 
Early onset pre-eclampsia, which represents 5-20% of all pre-eclampsia 
cases, is regarded as the more severe form of the disease, while late onset, which is 
the more common form, appears to be a milder form of the disease with a better 
maternal and perinatal outcome.8,20  
The early form is characterized by an early onset of sympathetic dominance 
in the maternal cardiovascular system with elevated circulation markers of 
endothelial dysfunction, inadequate trophoblast invasion and transformation of 
spiral arterioles, abnormal Doppler waveforms of the uterine arteries with 
notching. This form more commonly results in elective pre-term birth and birth of 
small for gestational age infants.8 
The late onset pre-eclampsia is more commonly superimposed upon a pre-
existing maternal condition associated with increased cardiovascular or metabolic 
risk of endothelial dysfunction (e.g. obesity, insulin resistance, diabetes mellitus, 
chronic hypertension and renal disease).8 The infants born to these mothers have a 
normal or slight higher birth weight than those of gestational age matched controls. 
The Doppler waveforms show much milder abnormalities in the uterine arteries 
than in the early onset form.8 
Pathologically the early onset form shows more vascular lesions (decidual 
vasculopathy) with more placental infarction, accelerated parenchymal maturation 
and smaller placentas.3 
Haemodynamically the early onset form shows a hypovolemic state with 
decreased cardiac output and increased total peripheral vascular resistance and on 
echocardiography the left ventricle size appears smaller. This denotes an under-
filling state with a pressure overload. Comparatively the late onset form shows a 
hyperdynamic state with increased cardiac output and decreased total peripheral 
vascular resistance. On echocardiography the left ventricle shows a large diameter 
measurement with a higher stroke volume. This denotes an overfilling state 
without a pressure overload.8 
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4.  PATHOLOGICAL CHANGES in the 
PLACENTA of PRE-ECLAMPSIA 
 
4.1.  Macroscopic Morphology 
Placentas of pre-eclampsia tend to have a more oval / oblong shape (Figure 1) 
rather than the circular shape (Figure 2) of normal placentas. This is due to 
the irregular trophoblast invasion of the decidua with the resultant ischemia 
and oxidative stress that results in villous necrosis and this leads to the 
irregular shape of the placenta. Also due to the above process, placentas 
from pre-eclampsia tend to be somewhat thicker than their gestational age 
matched controls.7  
The umbilical cords tend to be thin, <1cm in diameter as compared to 
gestational age matched controls.12 
 
Figure 1: Oval placental shape from a case of pre-eclampsia. 
 
 
Figure 2: Round placenta from, an uncomplicated pregnancy. 
 
4.2.  Weight 
The trimmed weight of the placentas tends to be lower than gestational age 
matched controls. This is particularly true for the more severe form, the 
early onset pre-eclampsia. Typically cases display placental weight below 
the 10th percentile for gestational age.7,20 
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4.3.  Histological features: 
The histological features associated with pre-eclampsia are similar to those seen 
in placentas from pregnancies with early intrauterine growth retardation 
(IUGR), namely those of reduced placental perfusion. These following 
changes are more prominently expressed in early onset pre-eclampsia than 
in the late onset group.  
Parenchymal features include accelerated maturation of the villi (when 
compared with that expected for gestational age), distal villous hypoplasia 
(these are small, slender villi which show reduced branching with very 
small terminal villi which lie in an expanded intervillous space and contain 
aggregated clusters of syncytiotrophoblastic nuclei)(Figure 3), increased 
syncytial knots (Figure 4), increased intervillous space and placental 
infarction (multiple and diffuse)(Figure 5).12 
 
Figure 3: Histological features of distal vil lous hypoplasia (H&E 100x).  
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Figure 4: Parenchyma with increased syncytial knots (H&E 100x).  
 
Figure 5: Placental parenchymal infarction right of centre with viable 
parenchyma left  of centre (H&E 40x).  
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Decidual vasculopathy includes incomplete vascular remodelling of spiral 
arterioles and acute atherosis (fibrinoid necrosis).  
Incompletely remodelled arterioles retain their muscular collars (Figure 
6) and predispose to spontaneous vasoconstriction and intermittent 
perfusion of the intervillous space, generating ischaemia-reperfusion 
injury. 18  
 
Figure 6: Incomplete vascular remodelling of spiral arterioles,  with the spiral 
arterioles maintaining their muscular coats and with perivascular lymphocytic 
infiltration (H&E 200x).  
 
The lesion of acute atherosis lesions have lipid-laden foamy cells 
(macrophages) being deposited beneath the endothelium with fibrinoid 
necrosis of the wall and occasionally leukocyte infiltration of the 
affected vessel (Figure 7).18 The foamy cells are CD68 positive 
macrophages. 18This lesion does not affect all spiral arterioles in the 
placenta, and seems to affect the decidual part of the spiral arteriole in 
particular. It does not affect the entire length of the arteriole and 
occasionally only part of the circumference is affected. It is thought 
that atherosis only is present in 20-40% of pre-eclamptic placentas.18  
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Figure 7: Acute atherosis of a decidual spiral arteriole (H&E 400x).  
 
This change causes subsequent narrowing of the lumen, thrombosis of the 
vessels and downstream ischemia and infarction.5 These lesions are 
restricted to the uterus and do not effect systemic maternal vessels in 
pre-eclampsia.6,18 
It is currently thought that the lesion of acute atherosis, which has a close 
histological resemblance to the early lesion of atherosclerosis, 
represents an inflammatory lesion rather than a lesion caused/induced 
by hypertension.6  
Placental abruption is also associated with pre-eclampsia, occurring with a 
higher frequency than in healthy patients. There does not appear to be a 
difference in the incidence of abruptio placenta between patients with pre-
eclampsia and in placentas from patients with IUGR without hypertension.  
20,21 The risk of placental abruption is similar in early and late onset pre-
eclampsia.20 However there is a statistical difference in the occurrence of 
abruption between late onset pre-eclampsia and gestational age matched 
controls.20  
Pathologically an abruption is seen as a retroplacental blood clot covering at 
least 15% of the disk surface area.22 Histologically the appearance of the 
haematoma varies with its duration. If an abruptio happens acutely and the 
placenta is delivered relatively quickly, there may be no histological 
evidence seen at all. If some time passes between development of the 
retroplacental haematoma and delivery than the haematoma can be seen to 
either to:  
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i) Dissect into the overlying parenchyma (this is due to pressure of 
the blood clot forcing it’s way into the placental parenchyma or  
ii) Cause overlying parenchymal infarction, due to cessation of 
maternal blood flow to that part of the parenchyma (Figure 8).  
iii) An retroplacental haematoma has been present for a considerable 
period of time (days to weeks) can cause an accumulation of 
hemosiderin laden macrophages to be present in the decidua or 
the haematoma can leach into the amnionic cavity causing 
hemosiderin laden macrophages to be seen in the chorionic plate 
of the placenta, so called chronic abruption.  
Intravillous haemorrhage is also a characteristic feature of an abruptio 
placenta.23 
 
These pathological findings that are encountered in most pre-eclampsia cases 
are not always present. In fact the placentas can appear grossly and 
histological appropriate for gestational age, even in cases with associated 
eclampsia.12 Therefore although these findings can be confirmatory/ 
supportive of pre-eclampsia, their absence cannot be used to exclude the 
diagnosis.12 
 




5.  SOLUBLE FACTORS of PRE-ECLAMPSIA 
The syncytiotrophoblast in response to oxidative stress secretes a host of 
substances that affect the maternal circulatory system. Important substances are 
soluble vascular endothelial growth factor receptor-1 (sVEGF or sFLT-1), soluble 
endoglin (sENG) and placental growth factor (PIGF).4 A healthy placenta secretes 
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a balanced amount of sFLT which leads to normal levels of provasodilatory and 
anticoagulant factors being available for binding to sFLT1 receptors on endothelial 
cells. In ischaemic placentas there is more sFLT and sENG secreted with less PIGF 
which bind to more circulatory factors leaving less of these factors to bind to 
endothelial cells, leading to systemic maternal endothelial dysfunction.4,23 
The use of pro- and anti-angiogenic factors has mainly been studied in early 
pre-eclampsia.   
 
6.  IMMUNOHISTOCHEMICAL PROPERTIES of 
INVADING TROPHOBLAST 
The invasive trophoblast is highly dependant on the expression of 
appropriate adhesion molecules on its cell surface for adequate invasion of the 
decidua and vascular tissues as well as for vascular remodelling.24 Failure to 
express adequate cell surface markers is indicative of a deficit in the invasive 
abilities of the intermediate cytotrophoblast.24 Zhou et al demonstrated that the 
cytotrophoblast, in pre-eclampsia, lacks expression of such adhesion markers, 
including VCAM-1, PECAM-1, VE-cadherin and ανβ3 integrins.25,26 Q Liu et al 
investigated the expression of CD146 (Mel-CAM) on invasive cytotrophoblast and 
found a decreased expression of this cell surface molecule in pre-eclamptic 
placentas when compared to normal controls.24 CD146, also known as melanoma 
cell adhesion molecule (Mel-CAM) is a member of the immunoglobulin gene 
superfamily.27 It is detected in only a limited number of normal tissues and 
tumours, namely melanoma, vascular endothelial cells, smooth muscle cells, 
implantation site intermediate trophoblast and activated T lymphocytes.24,27 In 
melanoma its expression level is associated with invasive and metastatic potential 
of the melanoma cells.28 
Furthermore CD146 takes part in interendothelial interactions as a calcium 
independent cell adhesion molecule. Participating in the outside-in signalling 
pathway that is associated with endothelial cell migration.29,30 CD146 is expressed 
on invasive intermediate trophoblast, but not on cytotrophoblast or 
syncytiotrophoblast.24 It appears to regulate the migration of intermediate 
trophoblast on smooth muscle.31 Liu Q et al investigated whether the expression of 
CD146 would be the same in the intermediate trophoblast in placentas from normal 
and pre-eclamptic placentas.24 They found that in normal placentas, CD146 was 
restricted to the endometrial vessels with the decidual cells exhibiting some 
background staining on the maternal side.24 On the fetal side CD146 stained the 
intermediate trophoblast in the uterine decidua as well as in the trophoblastic 
columns of anchoring villi. The staining was ‘strong’ and uniform, independent of 
the depth of trophoblastic invasion.  CD146 was not detected in the 
syncytiotrophoblast or cytotrophoblast of the anchoring or floating villi.24 This 
contrasted with pre-eclamptic placentas where the staining was remarkably 
reduced or undetectable in the invasive trophoblast in the decidua as well as the 
trophoblastic columns from anchoring villi, basal plate and remodelled maternal 
vessels.24  
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7.  HYPOTHESIS (aims & objectives) 
Based on the work performed by Liu Q et al24it was decided to perform 
similar research on pre-eclamptic placentas. Van der Merwe et al 20 performed a 
study at Tygerberg Hospital comparing early and late onset pre-eclamptic placental 
morphology to appropriately gestation-matched controls to establish any 
differences. It was decided to use this cohort of placentas for the following further 
research study. 
7.1.  CD146 expression in intermediate 
trophoblast in formalin fixed placentas in 
pre-eclamptic placentas differs when 
compared with gestational age matched 
controls.  
Liu Q et al.24 performed a similar study, but used fresh frozen tissue from 
placental bed and performed immunofluorescent staining, using dual 
labelling with CD146 and a polyclonal Cytokeratin stain. It is 
postulated that CD146 expression, on formalin fixed tissue, will be 
expressed less (weaker expression) on intermediate trophoblast in the 
placentas from pre-eclampsia as compared to gestational aged matched 
controls. 
 
7.2.  CD146 expression in intermediate 
trophoblast in placentas from early onset 
differs when compared to expression in late 
onset pre-eclampsia. 
Liu Q et al.24 showed that in pre-eclampsia the intermediate trophoblast 
shows a markedly diminished expression of CD146 when compared to 
intermediate trophoblast in normal placentas. However they did not 
compare early to late onset pre-eclampsia. Since the clinical 
presentation is markedly different between early and late onset pre-
eclampsia, it is thought that there should be a marked difference in 
CD146 expression in the intermediate trophoblast in the placentas in 
the two forms. It is hence postulated that the intermediate, invading 
trophoblast in the decidua from early onset pre-eclampsia placentas 
will express CD146 immunostain less as compared to the late onset 
pre-eclampsia placenta group. 
 
8.  METHODOLOGY and MATERIALS. 
 
8.1.  Study Setting and Ethics 
This study builds on the completed and published thesis of Dr JL van der 
Merwe.20 The current PI was a co-investigator in that study. 
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Placentas were collected as part of a case control study performed at 
Tygerberg Hospital, a secondary and tertiary referral academic hospital, in the 
Western Cape Province of South Africa. 
The study recruited patients over a 7-month period. There were 4 groups of 
patients, each group having 25 placentas, namely early and late onset pre-eclamptic 
pregnant women as well as control placentas matched for gestational age for each 
of the two pre-eclamptic groups.  
Written informed consent was obtained in writing from each of the study 
patients. Ethics consent was obtained form the Stellenbosch University Ethics 
Committee, no: N06/09/185. 
Ethics extension of this current study was obtained from Stellenbosch 
University and ethics consent was obtained from the University of Cape Town for 
the current study, no 634/2013. 








Teenage pregnancies (<18years of age), intrauterine deaths, neonatal deaths, 
multiple pregnancies and other subtypes of gestational hypertensive 
disorders (excluding pre-eclampsia). 
Current or previous maternal diseases, including diabetes mellitus and auto-
immune disease were also excluded. 
Retroviral disease with a CD4 count of less than 200. 
Woman with known idiopathic intra-uterine growth restriction were excluded. 
 
Control Group Placentas: 




Placentas = 50 
Gestational age 
matched controls = 50  
Early Control  
Group = 25 
Late Control  
Group = 25 
Early Onset Pre-
eclampsia = 25 
Late Onset Pre-
eclampsia = 25 
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Late control placentas were collected from uncomplicated normal vaginal 
deliveries at term or from normal vaginal deliveries after a previous 
Caesarean Section. 
 
8.2.  Processing of the Placentas. 
All collected placentas were fixed in 10% neutrally buffered formalin for a 
minimum period of 24 hours prior to sampling (as per our laboratories 
standard operating procedure).  
Placentas were described macroscopically and sectioned. One cassette contained 
two sections of the umbilical cord and a roll of the placental membranes. 
Three sections of the parenchyma were taken in which a minimum of one 
section contained the decidual plate and one contained the fetal surface of 
the placenta.  
After sectioning, the sections where processed as per routine practice for 
surgical specimens and embedded in paraffin wax blocks. 3-5µm sections 
where cut, placed on glass slides and stained with haematoxylin and eosin 
(H&E) stain and cover slipped.  
All the study cases were assigned a study number from 1 to 100 in the previous 
study. No patient particulars were used or were known in the current study. 
Only after the interpretation of the immunostaining were the cases 
identified as to their study group (early or late control or early or late pre-
eclampsia).  
 
8.3.  Immunohistochemical Staining. 
One section of the placental parenchyma that included the decidual surface was 
selected for immunohistochemical analysis for each of the two-
immunohistochemical stains. All immunostains where performed on 
formalin fixed, paraffin embedded material. 3-5µm sections were cut from 
each paraffin wax block for performance of the immunohistochemical 
stains. 
CD146 (MCAM / Mel-CAM) immunohistochemical antibody, clone N1238, 
was used from Novocastra, Leica. This is a mouse monoclonal antibody and 
positive staining shows a membranous staining pattern. The cytoplasm and 
nucleus do not stain. A dilution of 1:50 was used with heat induced antigen 
retrieval (HIER) for 20min. 
Anti-Human Pan Cytokeratin, clone MNF116, monoclonal mouse antibody 
from DAKO was used. A dilution of 1 in 500 was used with enzyme 
antigen retrieval technique for 10min. This stains the cytokeratin 
intermediate filaments of the cells and hence it is a cytoplasmic stain. 
Both immunohistochemical stains were performed on the Leica Vision 
Biosystems Bond Immunohistochemical automated stainer. The stains were 
performed according the standard operating procedure (SOP) that has been 
optimized for these antibodies in our laboratory. The immunostaining was 
performed in batches. All the cases were stained prior to evaluation/analysis 
of the material. 
 
8.4.  Analysis and Interpretation 
The antibodies CD146 and MNF were used to identify the intermediate 
trophoblast in the decidual plate. 
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Once the CD146 positive intermediate trophoblast was identified, an analysis 
was performed by counting the amount of intermediate trophoblast in the 
decidua. It was recorded if the intermediate trophoblast was diffusely 
present or in nodules of either <20 or >20 cells per nodule. The presence or 
absence of decidual giant cells was recorded.  
 
An objective analysis using the Nikon Eclipse TE2000-S microscopy and NIS-
Element basic research image analysis software was used to determine the 
amount of intermediate trophoblast in the decidua. First the surface area of 
the decidua was calculated using the software. Then the CD146 IT cells 
were selected and the total surface area of the IT staining with CD146 
calculated. A ratio of IT: total decidual surface area was calculated.  
 
8.5.  Statistical Analysis 
The statistics unit at Stellenbosch University was consulted to determine if there 
was any significant difference in the amount of intermediate trophoblast 
present in the decidua in the pre-eclampsia group vs. the control group. 
Additionally the staining of intermediate trophoblast in the early and late 
onset pre-eclampsia groups was analysed.  
 
 
9.  RESULTS 
 
9.1.   Immunohistochemical staining. 
MNF116 stained the intermediate trophoblast in the decidua as well as the cyto- 
and syncytiotrophoblast that surround the villi. This staining was strong, 
continuous with a clean background (Figure 10). 
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Figure 10: MNF116 staining of the IT in the decidua and the syncytiotrophoblast 
around the vil l i  (200x).  
 
CD146 showed a membranous staining pattern in the intermediate trophoblast 
in the decidua and also stained the fetal capillaries in the villi (Figure 11). 
 
Figure 11: CD146 shows staining of IT in the decidua with endothelial  cells  
staining of the fetal capillaries (100x).  
 
The CD146 stain also showed a considerable amount of granular, non-specific 
background staining (Figure 12). Additionally it stained a considerable 
number of decidual cells positive, though less intensely (Figure 13).  
Dr Pawel T. Schubert 
Anatomical Pathology                                                                                                                                                                   2014 
Universities of Stellenbosch & Cape Town                                                                                               Student No: SCHPAW001 
Master of Philosophy (Paediatric Pathology) 
University of Cape Town 
16 
 




Figure 13: CD146 IHC stain with weak staining of decidual cells  (blue arrows) 
while the IT stained much more intensely (green arrows) (200x).  
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Initially it was thought that it would be possible to distinguish the non-specific 
decidual staining from the true intermediate trophoblast.  However, it 
quickly became apparent that this task would be impossible to resolve 
without having dual immunohistochemical staining for MNF116 and 
CD146 performed on the same slide. The decidua contains many cells with 
non-specific staining.  
 
 
9.2.  Optical Analysis of the Intermediate 
Trophoblast staining. 
It was not possible to perform an objective analysis of the amounts of 
intermediate trophoblast in the decidua that stained with both CD146 and 
MNF116 immunostains as was initially outlined in the method section, as 
this was deemed too subjective and inaccurate. There were also more cells 
present in the decidua than initially anticipated. It was decided by the PI and 
supervisors (HW and CAW) that this would be too subjective an analysis 
and would not be a true representation of the distribution of the intermediate 
trophoblast in the decidua. This form of analysis was thus abandoned. 
 
9.3.  Analysis using Nikon software. 
The Nikon Eclipse TE 2000-S microscope NIS – Elements Basic Research 
image software were used to determine the surface area of the decidua.  
The problem that was encountered from the very beginning was with the 
selection of the intermediate trophoblast. CD146 is a membranous stain and 
not a cytoplasmic stain; hence it outlines the cells but does not fill in the 
cytoplasm (Figure 14). There is also a considerable amount of background 
staining and the decidual cells stain weakly. The software had to be set so 
that it would ‘fill in’ (colour in the cytoplasm between the brown 
membranous staining) in the intermediate trophoblast, but disregards the 
background staining and the staining of the decidual cells.  
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Figure 14: CD146 showing membranous staining with the cytoplasm being 
unstained (400x).  Note the background staining between the IT cells  (yellow 
arrows)(400x) 
 
In order to achieve this, the threshold (the amount of pixels/ intensity of the 
staining) had to be increased in an attempt to ‘unselect’ the falsely staining 
decidual cells. This is not as simple as it sounds, as this process involves 
decreasing the amount of pixels that would be in use (more pixels, result in 
darker staining). In doing this one loses definition of the tissues. This also 
leads to a decrease in the intensity of the intermediate trophoblast staining, 
making the borders less distinct. Some of the less intensely stained 
intermediate trophoblast also became unselected in the process. Figure 15 
illustrates this feature and is taken at a magnification of 200x. At this 
magnification it is already a problem, however when shown at 100x 
magnification this problem became even more severe, Figure 16. 
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Figure 15: CD146 stain -  note the difference in intensity of the circumferential 
membranous staining of the intermediate trophoblast in this group (200x).  
 
 
Figure 16: CD146 stain of the same region but at 100 x magnifications. Notice the 
difficulty in selecting cells  with the same staining intensity.    
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Another issue that also arose was that of background staining, which also turned 
out to be a major problem as the software selected all the background 
staining as part of the intermediate trophoblast staining. The background 
staining had the same intensity of staining as the intermediate trophoblast, 
hence it become impossible to unselect the background staining. The only 
way to unselect the background staining was to go on a very high 
magnification of 200x or preferably 400x magnification. The same issue 
arose with the high magnification as that discussed above.  
 
To perform analysis of the intermediate trophoblast surface area on a low 
magnification (20x or 40x) was not possible as the software either selected 
too much or too little intermediate trophoblast.  
Figure 17 illustrates CD146 staining of a decidual area. How many intermediate 
cells are there? The cells seem to staining strongly, however when 
compared to Figure 18, which illustrates MNF116 staining of the same area, 
there appears to be much less intermediate trophoblast than what was 
originally thought to be present. 
 
 
Figure 17: CD146 staining a decidual area (200x) 
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Figure 18: MNF stain of the same areas as in Figure 17, i l lustrating much less IT 
than originally thought to be present (200x). 
 
This would have resulted in an over- or underestimation of the trophoblast 
surface area. Since dual immunostaining was not performed, the problem of 
over- or underestimation of the amount of intermediate trophoblast could 
not be circumvented. 
 
The 40x magnification does not even bring all the decidual surface area into 
view either; this is illustrated in Figure 19, where in this example it took 9 
photos at 40x magnification to visualize the entire decidua. To overcome 
this problem one would have to start using magnifications of 200x or 400x, 
however in this setting one only looks at a small area of decidua and cells 
and performing this analysis would be not be representative of the entire 
surface area. To analyse the entire decidua at a magnification of 200x or 
400x would not be possible as it would have taken thousands of 
photographs and man hours to analyse all the cases in this study and hence 
this was not a viable solution. 
 
It was then thought to take 3 random photos of the decidua and to work out the 
surface area of the decidua and that of the intermediate trophoblast and to 
then get the ratio. However, there was no guidance in the literature as to 
which areas to select. Does one select hypercellular or hypocellular areas? 
Or must they be completely random? This was again thought, by the PI and 
supervisors, that this would not give an accurate representation of the 
intermediate trophoblast to decidual surface area ratio. 
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Help was sought from the Nikon representative for the Western Cape region. 
Troubleshooting was performed, but no acceptable improvement to the 
situation could be obtained. The software in use had not been optimized for 
the chromogenic immunohistochemical staining in our setting. The 
background immunohistochemical staining and the haematoxylin 
background nuclear and membranous staining turned out to impair the 
software. This program runs advanced protocols and just trying to 
understand this program was difficult in itself as it is very complicated and 
one has to work with this software on a daily basis to become proficient. 
Different methods were attempted in this program to circumvent the 
stumbling blocks that were encountered in trying to perform image analysis 
on our specimens. The steps that had to be followed became very 
complicated, and time consuming without additional advantages obtained. 
 
In areas the decidual outlines were very irregular, with areas of the decidua 
absent and in other areas the decidua tracked/extended into the parenchyma 
as a septum. It also became unclear where the cut off point of the decidua 
was in these septae. Hence every time a decidual surface area was 
calculated it produced different measurements.  
 
This was discussed in depth with the supervisors (HW and CAW) of this study 
and it was determined, that at this stage with the current tools at our 
disposal, it would not be possible to optimize this technique to make an 
objective, accurate and reproducible assessment/ analysis of the differences 
in staining between the pre-eclamptic placentas and gestational age matched 
controls, nor between the early and late onset pre-eclamptic placentas. This 
study with the immunohistochemical stains for CD146 and MNF116, would 
have to be postponed till a future date when a more sensitive and easier to 
operate image analysis software was available in order to perform this 




10.  DISCUSSION 
 
Pre-eclampsia is a disease that occurs in 5-8% of pregnancies and carries a 
high morbidity and mortality rate for both the mother and baby, in both first and 
third world countries.1,3 Pregnant mothers with pre-eclampsia are predisposed to 
abruptio placenta, disseminated intravascular coagulation, cerebral haemorrhage, 
liver and kidney failure (dysfunction).1 The fetus is predisposed to intrauterine 
growth retardation, premature delivery, hypoxic damage and intrauterine or 
neonatal death. 
At the basis of this disease is incomplete intermediate trophoblast invasion 
into the underlying decidua with incomplete remodelling of the spiral arterioles. 
This process starts early in pregnancy and continues till 20 weeks gestation.13 This 
leads to ischemic-reperfusion injuries of the placental parenchyma with resultant 
secretion of systemic substances into the maternal circulation that leads to the 
maternal phase of the disease. This has also become known as the two-stage model 
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of pre-eclampsia with the first stage comprising the pre-clinical placental 
injury/insult and the second stage referring to the clinical manifestation of the 
disease, that we recognize as pre-eclampsia.3,8 At the moment the diagnosis of pre-
eclampsia is made at the clinical (second) stage of the disease when the clinical 
features of pre-eclampsia manifest.2 New research is starting to emerge on 
biomarkers to try and recognize/diagnose the presence of disease in the first (pre-
clinical) stage of the disease. The forerunners of these are sFLT-1 and plasma 
ascorbate levels.7 sFLT-1 is a downstream marker of HIF (hypoxia response 
elements) activation, which is elevated, in pre-eclamptic woman with and without 
fetal growth restriction. Women with fetal growth restriction but without pre-
eclampsia do not have elevated levels of HIF-1α or HIF-2α, nor the proteins from 
their downstream transcription pathway.7 
 
Invasion by intermediate trophoblast into the decidua is mediated by a 
complex network of soluble autocrine and paracrine factors, signalling pathways 
and regulatory transcription factors.13 Although little is known as yet about all 
these factors, it appears the epidermal growth factor (EGF), vascular endothelial 
growth factor (vEGF) and various cytokines (e.g. IL-11) that are secreted by the 
endometrial glands play a role in controlling this process in the early stages.13 
The display of adhesion molecules on surface of intermediate trophoblast 
also plays a critical role, as the lack of such molecules is indicative of a deficit in 
the ability of intermediate trophoblast to successfully invade the underlying 
decidua and spiral arterioles. Some of these surface molecules include, ανβ3 
integrins, VE-cadherin, VCAM-1 and PECAM-1.24 CD146 is also a surface 
adhesion molecule that was demonstrated to be strongly expressed on intermediate 
trophoblast.31 Liu et al24 decided to investigate the expression of CD146 in pre-
eclamptic placentas. They took samples of decidua from the placental bed (size of 
sample not specified), froze the specimen and then performed dual labelled 
immunofluorescence for CD146 and an anti-cytokeratin polyclonal antibody 
immunostaining on this tissue. In this study they observed that the intermediate 
trophoblast demonstrated remarkably reduced to undetectable expression of 
CD146 when compared to the control group.15 This current study tried to 
determine if we could replicate these results on formalin fixed placental tissue and 
to determine if there would be a difference in CD146 expression between early and 
late onset pre-eclampsia as these two manifestation of pre-eclampsia seem to be 
two different diseases. Since early and late onset pre-eclampsia manifest vastly 
different clinical expressions 3,8,20, as described previously, we wondered if the 
intermediate trophoblast in these two diseases would express CD146 differently on 
its cell surface.  
 
Our study differed from Liu Q et al, in a few aspects, nl: 
We used formalin fixed tissue while they used fresh frozen placental 
bed tissue.  
We used immunohistochemical staining for CD146, Novocastra, 
mouse monoclonal antibody, clone N1238; while Liu Q used CD146, Santa 
Cruz Cooperation, CA, USA, mouse monoclonal antibody, clone AA98.  
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We used Anti-Human Cytokeratin, Dako, monoclonal mouse antibody, 
clone MNF116, Liu Q used Anti-Human Cytokeratin, Santa Cruz 
Cooperation, CA, USA, rabbit polyclonal antibody.  
We used single immunostaining per slide; Liu Q used dual 
immunostaining per slide. 
We stained the entire decidual surface and tried to analyse it, while Liu 
Q, though it is not formally stated in their article, appear to have only used 
a small biopsy of the decidual bed. 
We wanted to determine the extent of CD146 expression in terms of 
volume while Liu Q used intensity of staining expression. 
This current study did not have a favourable outcome due to the fact that the 
software could not be used to get a reliable, repeatable and accurate measurement 
of the ratio between surface area of the decidual surface and the volume of 
intermediate trophoblast present in the decidua. The variation in the intensity of 
staining in the CD146 in the intermediate trophoblast on the same slide 
complicated matters. This was further complicated by the non-specific, granular 
background staining and the staining of the decidual cells. It was difficult to move 
from the MNF slide to the CD146 slide to ensure the cells of interest were 
intermediate trophoblast cells and not decidual cells. Dual labelling 
immunostaining on the same slide would have circumvented this problem, but was 
unavailable to us.  
This software program does not seem to work as well on chromogenic 
immunohistochemical staining as it does on fluorescent immunofluorescence 
stained slides. The immunofluorescence has a much crisper staining quality to it 
and is on a black background, which helps with differentiation. This seems to make 
the software function much better. Also the majority of immunofluorescence 
analysis work performed on the system (from the PI investigation) appears to be on 
cell cultures which include only a few cells per high field (200-400x) 
magnification that are being evaluated at a time. This makes it much easier to 
analyze the staining.  
This latter point is important, as we thought that the more tissue we would 
have to analyse the more accurate we could be. However with the image analysis 
software that we used, as we were not scanning the entire slide, this was a problem 
as we were only looking at a restricted part of the slide and not the entire decidual 
surface. Again this was an unforeseen problem. In this regard had we chosen a 
smaller surface to stain and analyse the simpler it would have been as there would 
have been less variation in staining and less background staining. The entire 
surface could have been analysed at a much higher magnification where the 
analysis could have worked. Once one is forced to choose areas to analyse it 
becomes difficult, as there is bias in the areas one chooses. 
 
11.  CONCLUSION 
The way forward is in using immunoflorescent staining with dual labelling 
for CD146 and MNF116 antibodies. This would ensure correct identification of the 
intermediate trophoblast. The analysis of the IF staining is easier as there is less 
background staining with more contrast as there is a black background. This makes 
it easier for the software to perform its analysis. 
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Using less tissue (decidua) will also eliminate the tremendous amount of 
tissue that is available for analysis. Analysing this amount of decidua as in this 
current study becomes a very time consuming process. 
Additionally, if future attempts are to be made to try and determine the 
difference off expression (quantitative and qualitative) of immunohistochemical 
markers on IT; this should not be undertaken unless one has a good, solid 
knowhow of how to operate/manipulate the image analysis software that will be 
used for analysis. 
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